{"success":true,"data":{"pressRelease":{"id":"140284","rtpr_id":"nGNXmWLmh-20260910","ticker":"LOVE","exchange":"TSX","all_tickers":["LOVE"],"title":"Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth","author":"Globe Newswire","published_at":"2026-09-10T12:00:01.154Z","article_body":"MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc.\n(https://www.globenewswire.com/Tracker?data=jrPmP2OyzCzGq95yAJ4gJQkhDxheuA1gO6J1R8rNcf2W4awgOynWzUVkHtE8XpqkcgVsculeGbiP68qWW_KBTB_qulyl8DyqE__ad_8HG-A=)\n(“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE\n(https://www.globenewswire.com/Tracker?data=Drh8ch8q5qxn-NEbrOJKkSq93AjD-BW_OatuqwP-QtDqrY7O8dfW5TpAi1vrvz3ZtyRkP5zXnpD5yNsLDDDL9_j_pLDXT_5lRacy3lQ_HmE=))\n(OTCQX: LOVFF\n(https://www.globenewswire.com/Tracker?data=oTkHsok2SUZ04yPaJjUge4kpbSYbLVD6ADauh6A0f4y43iZDFYzhW8bqe6oRAWVtmItbj7Wz_tUvv7JSq-2mrGRha4LPRno9yJf97eMPsI_TtOnBKAF0WmUvBp7gO8wp))\n(FRA: 8CB0\n(https://www.globenewswire.com/Tracker?data=HVDFHNLaQiLegDOleFBr2AHn4uG1RpQptse7eL90LR3QWhzhJL-1tZQ1Ojd8RPr_lN0YZaj4d6TabOE4PJdGPhA1X8J3PYGVMPnWAIXlRMUlnpPNnujl-W48gqYSJ9Nx)),\na vertically integrated producer of premium-grade cannabis products at\naffordable prices with two mega facilities in Québec spanning over 1,600,000\nsq. ft., today announced that its operating subsidiary, Cannara Biotech (OPS)\nInc., has entered into an amended and restated syndicated credit agreement\n(the \"Restated Credit Facility\") with Bank of Montreal (\"BMO\") and The\nToronto-Dominion Bank (\"TD\"). The Restated Credit Facility provides Cannara\nwith $80 million of total committed borrowing capacity, representing a $30\nmillion increase from the approximately $50 million accessible immediately\nprior to refinancing. The new structure primarily refinances existing\nborrowings while providing additional liquidity for working capital and\nstrategic capital investments.\n\nBMO will continue to serve as administrative agent, syndication agent and sole\nbookrunner and, together with TD, will act as co-lead arranger. TD joins the\nlending syndicate as part of the expanded financing, broadening Cannara's\nbanking relationships and institutional lending support.\n\nThe Restated Credit Facility refinances Cannara's existing secured credit\nfacilities, increases the Company's committed revolving capacity from $10\nmillion to $40 million and extends the maturity date from December 31, 2027,\nto December 31, 2029. The expanded financing is intended to provide additional\nliquidity for working capital and general corporate requirements while\nsupporting continued capital investment at Cannara's Valleyfield facility.\n\n\"The establishment of an $80 million syndicated credit facility with two\nleading Canadian banks is a strong endorsement of the business we have built\nand the disciplined, profitable growth we continue to deliver,\" said Zohar\nKrivorot, Founder and Chief Executive Officer of Cannara. \"Adding TD alongside\nour longstanding relationship with BMO expands our banking platform and\nprovides Cannara with the financial capacity to execute on our next phase of\ngrowth in Canada and internationally.\"\n\n\"This refinancing meaningfully strengthens our capital structure by increasing\nour revolving capacity to $40 million, extending our maturity to December 2029\nand consolidating our existing facilities into a more flexible financing\npackage,\" said Niko Sosiak, Chief Operating Officer of Cannara. “I am\npleased to be joining Cannara at this important stage in its growth,” said\nNicholas Fozard, Cannara’s recently appointed Acting Chief Financial\nOfficer. “With the Restated Credit Facility now in place, I look forward to\nworking alongside the leadership team as we continue to invest with discipline\nin the Company’s growth priorities and build upon Cannara’s strong\nfinancial foundation.”\n\nRESTATED CREDIT FACILITY HIGHLIGHTS\n\nThe key changes represented by the Restated Credit Facility are described\nbelow.\n* $40 million term loan: The term loan will refinance amounts outstanding\nunder Cannara's existing term loan, capital expenditures facility and\nrevolving credit facilities, with the remaining proceeds available to fund\ncapital expenditures at the Valleyfield facility.\n* $40 million revolving credit facility: The committed revolver, increased\nfrom $10 million, is available through multiple draws for ordinary working\ncapital and general corporate requirements.\n* Extended maturity: Both facilities mature on December 31, 2029, extending\nthe Company's debt maturity by two years.\n* Updated Financial Covenants: The Restated Credit Facility also reflects\nrevised financial covenants that provide the Company with flexibility and\nliquidity to advance its previously announced expansion program at its\nValleyfield facility. The program includes the development of the Company’s\nnew post-processing centre, which is being designed to support EU-GMP\ncertification, and the activation of additional cultivation zones required to\nmeet growing demand. The Restated Credit Facility amends and restates the\nCompany's original credit agreement in a single, consolidated document, and\nthe Company's obligations under the original agreement continue uninterrupted\nunder the new terms. All other original terms and conditions of the Restated\nCredit Facility remain in full force and effect. For a full description of the\noriginal credit agreement, please refer to the Company’s Annual Information\nForm for the fiscal year ended August 31, 2025. A redacted copy of the\nRestated Credit Facility will be filed under the Company’s profile on SEDAR+\nat www.sedarplus.ca.\nCONTACT\n\nScott Carroll, PhD, MBA\nVice President, Investor Relations & Commercial Strategy\nscott.carroll@cannara.ca\n\nABOUT CANNARA\n\nCannara Biotech Inc.\n(https://www.globenewswire.com/Tracker?data=jrPmP2OyzCzGq95yAJ4gJQkhDxheuA1gO6J1R8rNcf1pMYcmn5PryZShkTmAd67QlRLThw5eIbQcxwNWt-qay3B2s0I5-OdsjqjIP7aUC5o=)\n(TSX: LOVE\n(https://www.globenewswire.com/Tracker?data=Drh8ch8q5qxn-NEbrOJKkb-EajEheC9FUDGbzuZvgG-S4wuTXjQvRL9ORoA6jAweOdYqYf8szHHUXtclBiQru7k3yxQeMTgduu6jWn1wgPs=))\n(OTCQX: LOVFF\n(https://www.globenewswire.com/Tracker?data=oTkHsok2SUZ04yPaJjUgewTimQiVta1nrNqhb0He7DW4w0aSZX24ROfk1ux7yHzz_8Zz63HQbXnyUByr0NTqzW86mqDcK0p6rufmjpUkUtIqWWjeSdU4IC0OSXBU4Nqw))\n(FRA: 8CB0\n(https://www.globenewswire.com/Tracker?data=HVDFHNLaQiLegDOleFBr2NHDuwZHVfx0l9xy_rcLgJkeC9lwq85b7KsqAWZzIHi-lacgeD7lJ44nMqGSbPB9sKGAjBWIb5Iz8eFuqjFVqxS9flgGwHG0aej4l-WKkBIqC5UfpJPRGINOODrnheX2gg==)),\nis a vertically integrated producer of affordable premium-grade cannabis and\ncannabis-derivative products. Cannara owns two mega facilities based in\nQuébec spanning over 1,600,000 sq. ft., providing the Company with 100,000 kg\nof potential annualized cultivation output. Leveraging Québec’s favourable\nenergy costs, Cannara maintains an efficient, low-cost production model. For\nmore information, please visit cannara.ca\n(https://www.globenewswire.com/Tracker?data=QuIJCM-7BxZFfeF_JArf_wZJ_ZR0NUkSLAFI-NsplLwutROtJEg0DoqAUBT7XFnaunXILdUkA3eCA5OFMgU8FQ==).\n\nCAUTIONARY STATEMENT REGARDING “FORWARD-LOOKING” INFORMATION\n\nThis news release may contain “forward-looking information” within the\nmeaning of Canadian securities legislation (“forward-looking statements”).\nThese forward-looking statements are made as of the date of this press release\nand the Company does not intend, and does not assume any obligation, to update\nthese forward-looking statements, except as required under applicable\nsecurities legislation. Forward-looking statements relate to future events or\nfuture performance and reflect Company management’s expectations or beliefs\nregarding future events and include, but are not limited to, not limited to,\nstatements regarding the intended use of proceeds from the expanded financing,\nincluding additional liquidity for working capital and general corporate\nrequirements and continued capital investment at the Valleyfield facility; the\nadvancement of Cannara's previously announced expansion program at\nValleyfield, including the development of the Company's new post-processing\ncentre and the activation of additional cultivation zones and the Company's\nability to support growing demand. In certain cases, forward-looking\nstatements can be identified by the use of words such as “plans,”\n“expects” or “does not expect,” “is expected,” “budget,”\n“scheduled,” “estimates,” “forecasts,” “intends,”\n“anticipates” or “does not anticipate,” or “believes,” or\nvariations of such words and phrases or statements that certain actions,\nevents or results “may,” “could,” “would,” “might” or “will\nbe taken,” “occur” or “be achieved” or the negative of these terms\nor comparable terminology. In this document, certain forward-looking\nstatements are identified by words including “may,” “future,”\n“expected,” “intends” and “estimates.” By their very nature,\nforward-looking statements involve known and unknown risks, uncertainties and\nother factors which may cause the actual results, performance, or achievements\nof the Company to be materially different from any future results, performance\nor achievements expressed or implied by the forward-looking statements.\n\nForward-looking information is based upon a number of assumptions and is\nsubject to a number of risks and uncertainties, many of which are beyond our\ncontrol, which could cause actual results to differ materially from those that\nare disclosed in, or implied by, such forward-looking information. These risks\nand uncertainties include, but are not limited to, the risk factors which are\ndiscussed in greater detail under “Risk Factors” in the Company’s AIF\navailable on SEDAR+ at www.sedarplus.ca and under the “Investor Area”\nsection of our website at https://www.cannara.ca/en/investor-area.\n\nOther risks not presently known to the Company or that the Company believes\nare not significant could also cause actual results to differ materially from\nthose expressed in its forward-looking statements. Although the\nforward-looking information contained herein is based upon what we believe are\nreasonable assumptions, readers are cautioned against placing undue reliance\non this information since actual results may vary from the forward-looking\ninformation. Certain assumptions were made in preparing the forward-looking\ninformation concerning the availability of capital resources, business\nperformance, market conditions, as well as customer demand. Consequently, all\nof the forward-looking information contained herein is qualified by the\nforegoing cautionary statements, and there can be no guarantee that the\nresults or developments that we anticipate will be realized or, even if\nsubstantially realized, that they will have the expected consequences or\neffects on our business, financial condition or results of operation. Unless\notherwise noted or the context otherwise indicates, the forward-looking\ninformation contained herein is provided as of the date hereof, and we do not\nundertake to update or amend such forward-looking information whether as a\nresult of new information, future events or otherwise, except as may be\nrequired by applicable law.\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/a6e0b6bb-8a70-42cb-b014-79d154afc270)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXmWLmh-20260910","title":"Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth","author":"Globe Newswire","ticker":"LOVE","created":"2026-09-10T12:00:01.154Z","tickers":["LOVE"],"exchange":"TSX","article_body":"MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc.\n(https://www.globenewswire.com/Tracker?data=jrPmP2OyzCzGq95yAJ4gJQkhDxheuA1gO6J1R8rNcf2W4awgOynWzUVkHtE8XpqkcgVsculeGbiP68qWW_KBTB_qulyl8DyqE__ad_8HG-A=)\n(“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE\n(https://www.globenewswire.com/Tracker?data=Drh8ch8q5qxn-NEbrOJKkSq93AjD-BW_OatuqwP-QtDqrY7O8dfW5TpAi1vrvz3ZtyRkP5zXnpD5yNsLDDDL9_j_pLDXT_5lRacy3lQ_HmE=))\n(OTCQX: LOVFF\n(https://www.globenewswire.com/Tracker?data=oTkHsok2SUZ04yPaJjUge4kpbSYbLVD6ADauh6A0f4y43iZDFYzhW8bqe6oRAWVtmItbj7Wz_tUvv7JSq-2mrGRha4LPRno9yJf97eMPsI_TtOnBKAF0WmUvBp7gO8wp))\n(FRA: 8CB0\n(https://www.globenewswire.com/Tracker?data=HVDFHNLaQiLegDOleFBr2AHn4uG1RpQptse7eL90LR3QWhzhJL-1tZQ1Ojd8RPr_lN0YZaj4d6TabOE4PJdGPhA1X8J3PYGVMPnWAIXlRMUlnpPNnujl-W48gqYSJ9Nx)),\na vertically integrated producer of premium-grade cannabis products at\naffordable prices with two mega facilities in Québec spanning over 1,600,000\nsq. ft., today announced that its operating subsidiary, Cannara Biotech (OPS)\nInc., has entered into an amended and restated syndicated credit agreement\n(the \"Restated Credit Facility\") with Bank of Montreal (\"BMO\") and The\nToronto-Dominion Bank (\"TD\"). The Restated Credit Facility provides Cannara\nwith $80 million of total committed borrowing capacity, representing a $30\nmillion increase from the approximately $50 million accessible immediately\nprior to refinancing. The new structure primarily refinances existing\nborrowings while providing additional liquidity for working capital and\nstrategic capital investments.\n\nBMO will continue to serve as administrative agent, syndication agent and sole\nbookrunner and, together with TD, will act as co-lead arranger. TD joins the\nlending syndicate as part of the expanded financing, broadening Cannara's\nbanking relationships and institutional lending support.\n\nThe Restated Credit Facility refinances Cannara's existing secured credit\nfacilities, increases the Company's committed revolving capacity from $10\nmillion to $40 million and extends the maturity date from December 31, 2027,\nto December 31, 2029. The expanded financing is intended to provide additional\nliquidity for working capital and general corporate requirements while\nsupporting continued capital investment at Cannara's Valleyfield facility.\n\n\"The establishment of an $80 million syndicated credit facility with two\nleading Canadian banks is a strong endorsement of the business we have built\nand the disciplined, profitable growth we continue to deliver,\" said Zohar\nKrivorot, Founder and Chief Executive Officer of Cannara. \"Adding TD alongside\nour longstanding relationship with BMO expands our banking platform and\nprovides Cannara with the financial capacity to execute on our next phase of\ngrowth in Canada and internationally.\"\n\n\"This refinancing meaningfully strengthens our capital structure by increasing\nour revolving capacity to $40 million, extending our maturity to December 2029\nand consolidating our existing facilities into a more flexible financing\npackage,\" said Niko Sosiak, Chief Operating Officer of Cannara. “I am\npleased to be joining Cannara at this important stage in its growth,” said\nNicholas Fozard, Cannara’s recently appointed Acting Chief Financial\nOfficer. “With the Restated Credit Facility now in place, I look forward to\nworking alongside the leadership team as we continue to invest with discipline\nin the Company’s growth priorities and build upon Cannara’s strong\nfinancial foundation.”\n\nRESTATED CREDIT FACILITY HIGHLIGHTS\n\nThe key changes represented by the Restated Credit Facility are described\nbelow.\n* $40 million term loan: The term loan will refinance amounts outstanding\nunder Cannara's existing term loan, capital expenditures facility and\nrevolving credit facilities, with the remaining proceeds available to fund\ncapital expenditures at the Valleyfield facility.\n* $40 million revolving credit facility: The committed revolver, increased\nfrom $10 million, is available through multiple draws for ordinary working\ncapital and general corporate requirements.\n* Extended maturity: Both facilities mature on December 31, 2029, extending\nthe Company's debt maturity by two years.\n* Updated Financial Covenants: The Restated Credit Facility also reflects\nrevised financial covenants that provide the Company with flexibility and\nliquidity to advance its previously announced expansion program at its\nValleyfield facility. The program includes the development of the Company’s\nnew post-processing centre, which is being designed to support EU-GMP\ncertification, and the activation of additional cultivation zones required to\nmeet growing demand. The Restated Credit Facility amends and restates the\nCompany's original credit agreement in a single, consolidated document, and\nthe Company's obligations under the original agreement continue uninterrupted\nunder the new terms. All other original terms and conditions of the Restated\nCredit Facility remain in full force and effect. For a full description of the\noriginal credit agreement, please refer to the Company’s Annual Information\nForm for the fiscal year ended August 31, 2025. A redacted copy of the\nRestated Credit Facility will be filed under the Company’s profile on SEDAR+\nat www.sedarplus.ca.\nCONTACT\n\nScott Carroll, PhD, MBA\nVice President, Investor Relations & Commercial Strategy\nscott.carroll@cannara.ca\n\nABOUT CANNARA\n\nCannara Biotech Inc.\n(https://www.globenewswire.com/Tracker?data=jrPmP2OyzCzGq95yAJ4gJQkhDxheuA1gO6J1R8rNcf1pMYcmn5PryZShkTmAd67QlRLThw5eIbQcxwNWt-qay3B2s0I5-OdsjqjIP7aUC5o=)\n(TSX: LOVE\n(https://www.globenewswire.com/Tracker?data=Drh8ch8q5qxn-NEbrOJKkb-EajEheC9FUDGbzuZvgG-S4wuTXjQvRL9ORoA6jAweOdYqYf8szHHUXtclBiQru7k3yxQeMTgduu6jWn1wgPs=))\n(OTCQX: LOVFF\n(https://www.globenewswire.com/Tracker?data=oTkHsok2SUZ04yPaJjUgewTimQiVta1nrNqhb0He7DW4w0aSZX24ROfk1ux7yHzz_8Zz63HQbXnyUByr0NTqzW86mqDcK0p6rufmjpUkUtIqWWjeSdU4IC0OSXBU4Nqw))\n(FRA: 8CB0\n(https://www.globenewswire.com/Tracker?data=HVDFHNLaQiLegDOleFBr2NHDuwZHVfx0l9xy_rcLgJkeC9lwq85b7KsqAWZzIHi-lacgeD7lJ44nMqGSbPB9sKGAjBWIb5Iz8eFuqjFVqxS9flgGwHG0aej4l-WKkBIqC5UfpJPRGINOODrnheX2gg==)),\nis a vertically integrated producer of affordable premium-grade cannabis and\ncannabis-derivative products. Cannara owns two mega facilities based in\nQuébec spanning over 1,600,000 sq. ft., providing the Company with 100,000 kg\nof potential annualized cultivation output. Leveraging Québec’s favourable\nenergy costs, Cannara maintains an efficient, low-cost production model. For\nmore information, please visit cannara.ca\n(https://www.globenewswire.com/Tracker?data=QuIJCM-7BxZFfeF_JArf_wZJ_ZR0NUkSLAFI-NsplLwutROtJEg0DoqAUBT7XFnaunXILdUkA3eCA5OFMgU8FQ==).\n\nCAUTIONARY STATEMENT REGARDING “FORWARD-LOOKING” INFORMATION\n\nThis news release may contain “forward-looking information” within the\nmeaning of Canadian securities legislation (“forward-looking statements”).\nThese forward-looking statements are made as of the date of this press release\nand the Company does not intend, and does not assume any obligation, to update\nthese forward-looking statements, except as required under applicable\nsecurities legislation. Forward-looking statements relate to future events or\nfuture performance and reflect Company management’s expectations or beliefs\nregarding future events and include, but are not limited to, not limited to,\nstatements regarding the intended use of proceeds from the expanded financing,\nincluding additional liquidity for working capital and general corporate\nrequirements and continued capital investment at the Valleyfield facility; the\nadvancement of Cannara's previously announced expansion program at\nValleyfield, including the development of the Company's new post-processing\ncentre and the activation of additional cultivation zones and the Company's\nability to support growing demand. In certain cases, forward-looking\nstatements can be identified by the use of words such as “plans,”\n“expects” or “does not expect,” “is expected,” “budget,”\n“scheduled,” “estimates,” “forecasts,” “intends,”\n“anticipates” or “does not anticipate,” or “believes,” or\nvariations of such words and phrases or statements that certain actions,\nevents or results “may,” “could,” “would,” “might” or “will\nbe taken,” “occur” or “be achieved” or the negative of these terms\nor comparable terminology. In this document, certain forward-looking\nstatements are identified by words including “may,” “future,”\n“expected,” “intends” and “estimates.” By their very nature,\nforward-looking statements involve known and unknown risks, uncertainties and\nother factors which may cause the actual results, performance, or achievements\nof the Company to be materially different from any future results, performance\nor achievements expressed or implied by the forward-looking statements.\n\nForward-looking information is based upon a number of assumptions and is\nsubject to a number of risks and uncertainties, many of which are beyond our\ncontrol, which could cause actual results to differ materially from those that\nare disclosed in, or implied by, such forward-looking information. These risks\nand uncertainties include, but are not limited to, the risk factors which are\ndiscussed in greater detail under “Risk Factors” in the Company’s AIF\navailable on SEDAR+ at www.sedarplus.ca and under the “Investor Area”\nsection of our website at https://www.cannara.ca/en/investor-area.\n\nOther risks not presently known to the Company or that the Company believes\nare not significant could also cause actual results to differ materially from\nthose expressed in its forward-looking statements. Although the\nforward-looking information contained herein is based upon what we believe are\nreasonable assumptions, readers are cautioned against placing undue reliance\non this information since actual results may vary from the forward-looking\ninformation. Certain assumptions were made in preparing the forward-looking\ninformation concerning the availability of capital resources, business\nperformance, market conditions, as well as customer demand. Consequently, all\nof the forward-looking information contained herein is qualified by the\nforegoing cautionary statements, and there can be no guarantee that the\nresults or developments that we anticipate will be realized or, even if\nsubstantially realized, that they will have the expected consequences or\neffects on our business, financial condition or results of operation. Unless\notherwise noted or the context otherwise indicates, the forward-looking\ninformation contained herein is provided as of the date hereof, and we do not\nundertake to update or amend such forward-looking information whether as a\nresult of new information, future events or otherwise, except as may be\nrequired by applicable law.\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/a6e0b6bb-8a70-42cb-b014-79d154afc270)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-10T12:00:01.661426748Z","server_sent_at_ms":1789041601661},"received_at":"2026-09-10T12:00:01.720Z","source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359444/0/en/cannara-expands-financing-to-an-80-million-syndicated-credit-facility-with-bmo-and-td-bank-further-strengthening-its-financial-foundation-for-continued-growth.html"},"analysis":{"id":"129181","press_release_id":"140284","analysis_json":{"industry":{"label":"Pharmaceuticals","sector":"Health Care"},"redFlags":["Credit agreement filed in redacted form — revised financial covenant details not disclosed","Facility primarily refinances existing borrowings; net incremental new liquidity is limited relative to headline $80M","CFO seat currently filled on an acting basis (Nicholas Fozard, recently appointed)"],"eventType":"debt_offering","narrative":"Cannara Biotech's operating subsidiary, Cannara Biotech (OPS) Inc., entered an amended and restated syndicated credit agreement with Bank of Montreal and The Toronto-Dominion Bank providing $80 million of total committed borrowing capacity, a $30 million increase from the approximately $50 million accessible immediately prior to refinancing.\n\nThe consolidated package comprises a $40 million term loan and a $40 million revolving facility, up from a $10 million revolver, with both facilities maturing December 31, 2029 — extending the company's debt maturity by two years.\n\nTD joins the lending syndicate as co-lead arranger while BMO remains administrative agent and sole bookrunner, with the structure providing liquidity for working capital and the Valleyfield expansion, including a new post-processing centre designed to support EU-GMP certification.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"TD joins BMO in an expanded $80M syndicated facility — two-bank endorsement, 4x revolver and a two-year maturity runway that funds Valleyfield growth without dilution."},"keyFigures":{"customDimensions":{"revolver":40000000,"term_loan":40000000,"new_maturity":"December 31, 2029","facility_sq_ft":1600000,"prior_maturity":"December 31, 2027","prior_revolver":10000000,"capacity_increase":30000000,"prior_capacity_approx":50000000,"maturity_extension_years":2,"total_committed_capacity":80000000,"potential_annualized_output_kg":100000}},"quotedText":"a strong endorsement of the business we have built","namedEntities":{"people":[{"name":"Zohar Krivorot","role":"Founder and Chief Executive Officer"},{"name":"Niko Sosiak","role":"Chief Operating Officer"},{"name":"Nicholas Fozard","role":"Acting Chief Financial Officer (recently appointed)"},{"name":"Scott Carroll","role":"Vice President, Investor Relations & Commercial Strategy"}],"products":[],"companies":[{"name":"Cannara Biotech Inc.","ticker":"LOVE","relationship":"filer"},{"name":"Cannara Biotech (OPS) Inc.","relationship":"operating subsidiary / borrower"},{"name":"Bank of Montreal (BMO)","relationship":"administrative agent, syndication agent, sole bookrunner, co-lead arranger"},{"name":"The Toronto-Dominion Bank (TD)","relationship":"lender joining syndicate, co-lead arranger"}],"dollarAmounts":[{"amount":"$80 million","context":"total committed borrowing capacity under Restated Credit Facility"},{"amount":"$30 million","context":"increase in borrowing capacity versus pre-refinancing level"},{"amount":"$50 million","context":"approximate borrowing capacity accessible immediately prior to refinancing"},{"amount":"$40 million","context":"term loan component refinancing existing facilities and funding Valleyfield capex"},{"amount":"$40 million","context":"committed revolving credit facility, increased from $10 million"},{"amount":"$10 million","context":"prior committed revolving capacity"}]},"materialImpact":{"score":3,"reasoning":"Cannara expanded committed borrowing capacity by $30M to $80M, quadrupled its revolver from $10M to $40M, extended maturity two years to December 2029, and added TD as a new lender alongside BMO — all without equity dilution. It is a meaningful balance-sheet strengthening for a small-cap cannabis producer, though primarily a refinancing rather than a market-moving event."},"tickerRelevance":{"others":[{"ticker":"LOVFF","relevance":"same issuer — OTCQX listing"},{"ticker":"8CB0","relevance":"same issuer — Frankfurt listing"}],"primary":"LOVE"},"globalImportance":25,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap (TSX-listed cannabis producer, OTCQX in US)","eventGravity":"credit facility expansion / refinancing, no dilution","sectorWeight":"cannabis — niche but retail-followed","issuerAuthored":true,"liquidityImpact":"$30M incremental capacity and 2-year maturity extension materially de-risk near-term funding"}},"event_type":"debt_offering","event_type_secondary":null,"sentiment":"bullish","material_impact_score":3,"narrative":"Cannara Biotech's operating subsidiary, Cannara Biotech (OPS) Inc., entered an amended and restated syndicated credit agreement with Bank of Montreal and The Toronto-Dominion Bank providing $80 million of total committed borrowing capacity, a $30 million increase from the approximately $50 million accessible immediately prior to refinancing.\n\nThe consolidated package comprises a $40 million term loan and a $40 million revolving facility, up from a $10 million revolver, with both facilities maturing December 31, 2029 — extending the company's debt maturity by two years.\n\nTD joins the lending syndicate as co-lead arranger while BMO remains administrative agent and sole bookrunner, with the structure providing liquidity for working capital and the Valleyfield expansion, including a new post-processing centre designed to support EU-GMP certification.","key_figures":{"customDimensions":{"revolver":40000000,"term_loan":40000000,"new_maturity":"December 31, 2029","facility_sq_ft":1600000,"prior_maturity":"December 31, 2027","prior_revolver":10000000,"capacity_increase":30000000,"prior_capacity_approx":50000000,"maturity_extension_years":2,"total_committed_capacity":80000000,"potential_annualized_output_kg":100000}},"named_entities":{"people":[{"name":"Zohar Krivorot","role":"Founder and Chief Executive Officer"},{"name":"Niko Sosiak","role":"Chief Operating Officer"},{"name":"Nicholas Fozard","role":"Acting Chief Financial Officer (recently appointed)"},{"name":"Scott Carroll","role":"Vice President, Investor Relations & Commercial Strategy"}],"products":[],"companies":[{"name":"Cannara Biotech Inc.","ticker":"LOVE","relationship":"filer"},{"name":"Cannara Biotech (OPS) Inc.","relationship":"operating subsidiary / borrower"},{"name":"Bank of Montreal (BMO)","relationship":"administrative agent, syndication agent, sole bookrunner, co-lead arranger"},{"name":"The Toronto-Dominion Bank (TD)","relationship":"lender joining syndicate, co-lead arranger"}],"dollarAmounts":[{"amount":"$80 million","context":"total committed borrowing capacity under Restated Credit Facility"},{"amount":"$30 million","context":"increase in borrowing capacity versus pre-refinancing level"},{"amount":"$50 million","context":"approximate borrowing capacity accessible immediately prior to refinancing"},{"amount":"$40 million","context":"term loan component refinancing existing facilities and funding Valleyfield capex"},{"amount":"$40 million","context":"committed revolving credit facility, increased from $10 million"},{"amount":"$10 million","context":"prior committed revolving capacity"}]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-10T12:08:38.403Z","global_importance":25,"audience_relevance":20,"importance_components":{"tickerTier":"small-cap (TSX-listed cannabis producer, OTCQX in US)","eventGravity":"credit facility expansion / refinancing, no dilution","sectorWeight":"cannabis — niche but retail-followed","issuerAuthored":true,"liquidityImpact":"$30M incremental capacity and 2-year maturity extension materially de-risk near-term funding"}},"durationMs":39030,"modelName":"glm-5.3-flash"}}